NASDAQ : NORD
Nordicus Partners Corporation — Company profile
Industrials · Consulting Services · United States
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Nordicus Partners Corporation, a biotech company specializing in developing breakthrough therapeutics for diseases with unmet medical needs in the United States. It develops medicines supporting oral health. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023. Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.
Details
| Name | Nordicus Partners Corporation |
| Sector | Industrials |
| Industry | Consulting Services |
| Founded | 1993 |
| Ceo | Henrik Rouf |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| Isin | US28265K3041 |
| Cusip | 28265K304 |
| Cik | 0001011060 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Henrik Rouf | Chief Executive Officer and President |
| Bennett Jay Yankowitz | Chief Financial Officer and Director |
Contact
| Address | 280 South Beverly Dr, Suite 505, Beverly Hills, California 90212, United States |
| Phone | 310 666 0750 |
| Website | https://nordicuspartners.com |